Augustin, M, J Wegtowska, M Lebwohl, C Paul, V Piguet, H Sofen, A Blauvelt, L Peterson, and Et al. “Durability of Response in Patients With Chronic Plaque Psoriasis Treated With Certolizumab Pegol over 48 Weeks: Pooled Results from Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT)”. SKIN The Journal of Cutaneous Medicine 20 (December 17, 2018): S87. Accessed December 2, 2020. https://jofskin.org/index.php/skin/article/view/484.